BamSEC and AlphaSense Join Forces
Learn More

MetaVia Inc. – Underwriting Agreements

NASDAQ: MTVA    
Share price (6/2/26): $2.71    
Market cap (6/2/26): $14.0 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.1
from 8-K 51 pages 614,840 Shares of Common Stock, 1,998,704 Pre-Funded Warrants to Purchase Up to 1,998,704 Shares of Common Stock, 3,920,316 Series C Warrants to Purchase Up to 3,920,316 Shares of Common Stock and 3,920,316 Series D Warrants to Purchase Up to 3,920,316 Shares of Common Stock of MetaVia Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 50 pages [___] Shares of Common Stock, [___] Pre-Funded Warrants to Purchase Up to [___] Shares of Common Stock, [___] Series C Warrants to Purchase Up to [___] Shares of Common Stock and [___] Series D Warrants to Purchase Up to [___] Shares of Common Stock of MetaVia Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1 50 pages ___ Shares of Common Stock, ___ Pre-Funded Warrants to Purchase Up to ___ Shares of Common Stock and ___ Series C Warrants to Purchase Up to ___ Shares of Common Stock ​ of MetaVia Inc. Underwriting Agreement
12/34/56
EX-1.1
from 10-Q 44 pages At the Market Offering Agreement ​
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Joint Acquisition Statement Pursuant to Section 240.13d-1
12/34/56
EX-1.1
from 8-K 46 pages 2,397,003 Shares of Common Stock, 2,602,997 Shares of Series B Convertible Preferred Stock (Convertible Into 2,602,997 Shares of Common Stock), 5,000,000 Series a Warrants (Exercisable for 5,000,000 Shares of Common Stock) and 5,000,000 Series B Warrants (Exercisable for 5,000,000 Shares of Common Stock) of NeuroBo Pharmaceuticals, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 45 pages Shares of Common Stock, Shares of Series B Convertible Preferred Stock (Convertible Into Shares of Common Stock), Series a Warrants (Exercisable for Shares of Common Stock) and Series B Warrants (Exercisable for Shares of Common Stock) of NeuroBo Pharmaceuticals, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 44 pages Shares of Common Stock and Shares of Series B Convertible Preferred Stock (Convertible Into Shares of Common Stock) and Warrants (Exercisable for Shares of Common Stock) of NeuroBo Pharmaceuticals, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 42 pages 3,142,858 Shares Gemphire Therapeutics Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.2
from S-3 35 pages Gemphire Therapeutics Inc. Equity Distribution Agreement
12/34/56
EX-1
from SC 13G 1 page Joint Filing Agreement
12/34/56
EX-1.1
from S-1/A 39 pages [·] Shares Gemphire Therapeutics Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1 39 pages [·] Shares Gemphire Therapeutics Inc. Underwriting Agreement
12/34/56